Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive Cancers.
Marchini C, Kalogris C, Garulli C, Pietrella L, Gabrielli F, Curcio C, Quaglino E, Cavallo F, Amici A. Marchini C, et al. Among authors: kalogris c. Front Oncol. 2013 May 14;3:122. doi: 10.3389/fonc.2013.00122. eCollection 2013. Front Oncol. 2013. PMID: 23675574 Free PMC article.
The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.
Marchini C, Gabrielli F, Iezzi M, Zenobi S, Montani M, Pietrella L, Kalogris C, Rossini A, Ciravolo V, Castagnoli L, Tagliabue E, Pupa SM, Musiani P, Monaci P, Menard S, Amici A. Marchini C, et al. Among authors: kalogris c. PLoS One. 2011 Apr 29;6(4):e18727. doi: 10.1371/journal.pone.0018727. PLoS One. 2011. PMID: 21559085 Free PMC article.
Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).
Gabrielli F, Salvi R, Garulli C, Kalogris C, Arima S, Tardella L, Monaci P, Pupa SM, Tagliabue E, Montani M, Quaglino E, Stramucci L, Curcio C, Marchini C, Amici A. Gabrielli F, et al. Among authors: kalogris c. PLoS One. 2013;8(3):e58358. doi: 10.1371/journal.pone.0058358. Epub 2013 Mar 28. PLoS One. 2013. PMID: 23555577 Free PMC article.
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.
Tilio M, Gambini V, Wang J, Garulli C, Kalogris C, Andreani C, Bartolacci C, Elexpuru Zabaleta M, Pietrella L, Hysi A, Iezzi M, Belletti B, Orlando F, Provinciali M, Galeazzi R, Marchini C, Amici A. Tilio M, et al. Among authors: kalogris c. Cancer Lett. 2016 Oct 10;381(1):76-84. doi: 10.1016/j.canlet.2016.07.028. Epub 2016 Jul 27. Cancer Lett. 2016. PMID: 27475932